Prestige Consumer Healthcare
PBH
$64.65
Share price
-0.51%
Change (1 day)
9.15%
Change (1 year)
Categories
Prestige Consumer Healthcare (PBH) - Total debt
Total debt on the balance sheet as of December 2023 : $1.21 B
According to Prestige Consumer Healthcare's latest financial reports the company's total debt is $1.21 B. A company’s total debt is the sum of all current and non-current debts.
Prestige Consumer Healthcare - Total debt on balance sheet (from 2004 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-03-31 | $1.36 B | -9.25% |
| 2022-03-31 | $1.50 B | -0.55% |
| 2021-03-31 | $1.51 B | -14.27% |
| 2020-03-31 | $1.76 B | -1.78% |
| 2019-03-31 | $1.79 B | -9.75% |
| 2018-03-31 | $1.99 B | -9.15% |
| 2017-03-31 | $2.19 B | 34.97% |
| 2016-03-31 | $1.62 B | 4.1% |
| 2015-03-31 | $1.56 B | 67.09% |
| 2014-03-31 | $0.93 B | -3.76% |
| 2013-03-31 | $0.97 B | -13.61% |
| 2012-03-31 | $1.12 B | 130.81% |
| 2011-03-31 | $0.48 B | 50.22% |
| 2010-03-31 | $0.32 B | -14.32% |
| 2009-03-31 | $0.37 B | -8% |
| 2008-03-31 | $0.41 B | -11.25% |
| 2007-03-31 | $0.46 B | -7.08% |
| 2006-03-31 | $0.49 B | 0.66% |
| 2005-03-31 | $0.49 B | 233.14% |
| 2004-03-31 | $0.14 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $33.63 B | 2,671.46% | 🇺🇸 USA |
 Procter & Gamble PG | $31.98 B | 2,535.50% | 🇺🇸 USA |
 Novartis NVS | $27.28 B | 2,148.35% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 5,738.02% | 🇺🇸 USA |
 Abbott Laboratories ABT | $15.62 B | 1,187.83% | 🇺🇸 USA |
 Clorox CLX | $3.02 B | 148.86% | 🇺🇸 USA |
 CVS Health CVS | $81.79 B | 6,640.12% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.45 B | 1,750.75% | 🇬🇧 UK |
 Rite Aid
RAD | $6.58 B | 442.33% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | $1.95 M | -99.84% | 🇮🇱 Israel |